I operate at the intersection of AI, human genetics, and commercial strategy. At Genomics, I help pharmaceutical and biotech organizations bring large-scale human genetics into earlier, more confident R&D decision-making—through a combination of advanced analytics, AI-enabled tooling, and strategic consulting support.

My work centers on partnering with senior R&D, statistical genetics, and strategy leaders to operationalize genetics across the pipeline: accelerating target discovery, strengthening validation, improving translational confidence, and identifying patient populations more likely to respond to therapy.

Over the past 20 years, I’ve:

•	Built, led, and mentored high-performing sales teams in AI and SaaS.
•	Managed global accounts and developed go-to-market strategies that drive adoption.
•	Closed multi-million-dollar enterprise engagements and partnerships across R&D industries 
•	Negotiated strategic agreements that expand revenue and accelerate growth.

I’m also the author of Mastering AI Sales: Essential Knowledge for B2B Professionals, a practical playbook that equips founders, consultants, and sales leaders with frameworks to win complex AI sales.
👆 Now available – click the link in my profile header to get your copy.

Specialties

•	AI-Enabled Human Genetics / Genomics Commercial Strategy
•	Building & Scaling Sales Teams
•	Enterprise AI Sales & Stakeholder Management
•	Go-to-Market Strategy (Consulting + Product Hybrid Models)
•	Strategic Partnerships & Revenue Expansion
•	Cross-Functional Leadership & Commercial Alignment

Let’s connect if you’re scaling AI solutions, leading enterprise transformations, or looking to accelerate sales impact in complex markets.

David Walker

Early JPM takeaways…

• Causal genetics is firmly front and center, increasingly used to de-risk target identification and validate programs earlier in development.
• Patient stratification is no longer optional. Leaders are entering the clinic with greater emphasis on clear responder hypotheses and stronger supporting evidence.
• AI is maturing quickly. Fewer proof-of-concept discussions, more concrete examples of measurable impact across R&D.
• Funding sentiment appears cautiously improved, particularly for companies with differentiated science and disciplined, evidence-led strategies.

The Genomics leadership team is here all week and we’d be happy to connect and compare notes.

#jpm2026 #Genomics

VP of Client Service | Leading Enterprise AI Partnerships | Team Builder | Author of Mastering AI Sales | MBA, MSc.

JPM was an outstanding experience. The energy, quality of conversations, and level of innovation throughout the week were exceptional.

We were delighted to host a Genomics reception, where we shared how Mystra, our AI enabled platform, enables teams to apply human genetics more effectively to R&D decision-making. The depth of engagement reinforced just how central genetics has become to smarter target selection and clinical decisions.

A few key takeaways stood out for me…

1. Platforms must change decisions
AI creates value only when it changes decisions e.g. which targets advance, which programs stop earlier, and which patients enter trials. The strongest platforms enable fewer, higher-confidence bets.

2. Data advantage ≠ more data
The ultimate advantage is signal, not scale. Rare disease cohorts, longitudinal datasets, and multi-omics data with clinical context enable better questions to be asked and reduce false confidence.

3. Causal genetics is becoming foundational
Human genetics is increasingly being used to improve probability of success, de-risk programs earlier, enable patient stratification, and support smarter trial design.

The next phase of R&D won’t be defined by who moves fastest, but by who makes the best decisions earliest, using well-curated data, causal evidence, and AI together.

#JPM26 #Genetics #TargetValidation #PatientStratification #DrugDevelopment

I am looking forward to participating in the 25th Precision Medicine World Conference (PMWC 2026), taking place March 4–6, at the Santa Clara Convention Center in California, co-hosted by Stanford, UCSF & Yale.

Meet me at #PMWC26, March 4-6, where over 400 speakers, including Nobel Laureates Mary Brunkow and W.E. Moerner, OpenAI's President & Co-Founder, FDA Commissioner (Fmr), Judy Faulkner (Epic), Carl June (UPenn), David Sinclair (Harvard) & more will gather to help advance precision medicine & AI.

Speakers: www.PMWCintl.com/Speakers
Program: www.PMWCintl.com/Program

Register for PMWC 2026 to save using my personal code: https://lnkd.in/e9MQeSUr

 PMWC - Precision Medicine World Conference
#PMWC26 #PMWC2026 #PrecisionMedicine #Biotech

Open article: PMWC 2026 Registration, Tickets & Pricing by pmwcintl.com

PMWC 2026 Registration, Tickets & Pricing

Great to see the Genomics team out in force at #FOG2026 
If you’re at FOG, make sure you stop by by Booth #77 to say hello and check out the Mystra D&D Quest, a fun, hands-on way to experience how we support drug target discovery and development through human genetics and multi-omics.   Plus Dirk Paul, Head of Development, talking about: “The Genome and Beyond: Advancing Drug Discovery and Development” Today 12:00–12:30 | Multi-Omics Stage
Have a great show, team 👋
#DrugDiscovery #MultiOmics #Genomics #DrugDevelopment #FOG2026 #FrontLineGenomics

Day 1 at #FOG2026 is here 🚀 

You can find us at Booth #77 - come say hello to the team and try our iconic Mystra D&D Quest 🧙 - an interactive challenge that gives you a hands-on experience with our drug target discovery and development platform! 

🎤 Today | 12:00 - 12:30 | Multi-Omics stage
Join Dirk Paul, Head of Development, for "The Genome and Beyond: Advancing Drug Discovery and Development"
What to expect:
💡 Insights into Genomics' genotype-phenotype platform & analytical pipelines
🧬  A deep dive into how multi-omics integration drives target identification & data-driven patient stratification
🌍  Real-world case case studies showcasing risk prediction and pharmacomimetic approaches in action

See you on the floor 👋 

#drugdiscovery #MultiOmics #Genomics #DrugDevelopment Front Line Genomics

I'll be heading to JPM next week. If you’ll be there too, drop me a message, it’d be great to connect in person.

🎉 We're starting the year in San Francisco! Our team will be arriving later this week for the J.P. Morgan Healthcare Conference.

We are looking forward to a busy few days connecting with colleagues from the Department for Business and Trade, and senior leaders across pharma and biotech.

From Saturday, January 10th, our CEO and Co-Founder, Professor Sir Peter Donnelly, President David Thornton, VP of Client Service David Walker, and Director of Communications Zuzanna Grzeskiewicz will be on the ground in San Francisco, ready to connect.

If you're going to be in San Francisco next week and would like to meet with our team, click here: https://lnkd.in/eT9qFMyy

See you soon! 🚀 

#JPM2026 #JPMWeek #techbio #genomics #JPM #pharma #biotech #healthcare #SanFran

Potentia Search

Potentia-Search offers a bespoke search and selection service across a number of key industries. I am currently serving the Life Science market on a Global Scale. 

• Developed specialized talent networks in AI/ML and Drug Discovery, reducing time-to-hire by 35%
• Built strategic partnerships with 20+ leading life sciences organizations
• Achieved 95% placement retention rate through precise cultural and technical matching

We have had the opportunity to work with Industry-leading Life Science companies among many others and now have excellent relationships with those Clients that have accelerated our success. Not only do we work with MNCs but we also assist growing Start-ups that are looking to expand their service lines and add to their teams.

With access to a wealth of talent, and a vigorous screening process, we ensure our client’s needs are met on a technical and cultural level to help drive their long-term growth plans. We work with candidates with varying levels of experience, ranging from C-level executives to mid-level management.

Email: Damhan.Sanderson@potentia-search.com
Direct line: +44 (0) 113 467 6073

Senior Business Consultant

Irving Knight Group

Irving Knight offer a bespoke search and selection service across a number of key industries. I am currently serving the Bioinformatics market on a Global Scale. We have had the opportunity to work with Industry-leading Bioinformatics companies among many others and now have excellent relationships with those Clients that have accelerated our success. Not only do we work with MNCs but we also assist growing Start-ups that are looking to expand their service lines and add to their teams.

With access to a wealth of talent, and a vigorous screening process, we ensure our client’s needs are met on a technical and cultural level to help drive their long-term growth plans. We work with candidates with varying levels of experience, ranging from C-level executives to mid-level management.

I am interested to speak with experienced individuals, who are either in a position to take on additional personnel or who are themselves looking for new opportunities. I encourage you to contact me to discuss any potential recruitment requirements you may have and the most effective and suitable strategy moving forward.

Email: Damhan.Sanderson@IrvingKnight.com
Direct line: +44 (0) 113 467 6073

Global Business Consultant

Bridging the talent gap in MedTech innovation, where cutting-edge technology meets breakthrough medicine.

With specialised focus on MedTech, Bio-pharma, Biotech  and AI/ML, I partner with industry-leading organisations and high-growth startups to build world-class teams. My expertise spans the complete MedTech landscape - from Drug Discovery, Lab Management and Precision Medicine to Diagnostic Imaging and Therapeutic Devices .

✓ Executive Search for VP to C-level positions
✓ Technical talent acquisition in emerging biotech
✓ Strategic hiring consultation for scaling companies
✓ Global talent network across key life science hubs

Let's connect to discuss:
• Building your next winning team
• Exploring career opportunities in life sciences
• Strategic talent acquisition planning

Contact: damhan.sanderson@potentia-search.com
Direct: +44 (0) 7826 423 156

taplio

The Battle

David Walker

Damhan Sanderson

Followers

Posts

Engagements

Likes

Performance ScoreDavid Walker's LinkedIn Performance

Ready to grow your LinkedIn presence?

taplio

The Battle

David Walker

Damhan Sanderson

Followers

Posts

Engagements

Likes

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}David Walker's LinkedIn Performance

Ready to grow your LinkedIn presence?

Performance ScoreDavid Walker's LinkedIn Performance